Institute of Cardiovascular Sciences We are leaders in cardiovascular research, including atrial fibrillation and heart failure, thrombosis and haemostasis, and vascular biology.
News Researchers make miniature ‘bone marrows in a dish’ to improve anti-cancer treatments The organoids provide a micro-environment that can accept and support the survival of cells from patients with blood malignancies
News Professor of Metabolism and Inflammation awarded £828K British Heart Foundation Research Fellowship
02 December 2022 Abnormal heartbeat identified in 1 in 20 older adults using wrist-worn wearable and smartphone A new study, conducted by the Atrial Fibrillation NETwork (AFNET), offered smartphone and arrhythmia screening to older adults without atrial fibrillation.
23 November 2022 World’s first clinical trial to test new drug glenzocimab for heart attacks New partnership with Acticor Biotech will see patients with heart attacks treated with glenzocimab, a promising new class of drug for the first time.
15 November 2022 Researchers make miniature ‘bone marrows in a dish’ to improve anti-cancer treatments The organoids provide a micro-environment that can accept and support the survival of cells from patients with blood malignancies
20 October 2022 Dr Gill Lowe appointed as national haematology lead at NIHR Dr Gill Lowe in the Institute of Cardiovascular Sciences, University of Birmingham has been appointed National Haematology Specialty Lead
14 October 2022 New £30M research injection to improve treatment of inflammatory diseases Renewed National Institute for Health and Care Research Birmingham Biomedical Research Centre continue funds for developments around inflammatory diseases
13 October 2022 Dr Melanie Madhani receives Japan Society for the Promotion of Science Fellowship Award Dr Melanie Madhani has been internationally recognised by the Japan Society for the Promotion of Science (JSPS) for her outstanding research.
28 September 2022 Targeting mast cells could be beneficial to treat Covid-19 patients New research uncovers the role of mast cells in Covid-19, and mast cell stabilizers could be efficient and safe in tackling the blockage of blood vessels.
16 September 2022 Professor of Metabolism and Inflammation awarded £828K British Heart Foundation Research Fellowship Professor Claudio Mauro has been awarded a British Heart Foundation Senior Research Fellowship towards research in immunometabolism in atherosclerosis.
01 September 2022 Anticlotting hope after rare genetic defect discovery New research with families in Chile looking at a rare genetic defect suggests that new, more powerful drugs to prevent dangerous clotting would be safe.
29 August 2022 Global digital health leaders propose framework for healthcare data research Healthcare data research should follow a framework to ensure transparency at every stage, according to experts across research, regulation and patient advocacy.
28 June 2022 Cardiovascular Science researchers awarded grant to develop new treatments for autoimmune conditions The researchers will undertake the project to improve the outcome for patients diagnosed with autoimmune conditions, such as rheumatoid arthritis or psoriasis.
03 May 2022 Birmingham cardiovascular scientists appointed editor and deputy editor of international journals Professor Neil Morgan and Dr Davor Pavlovic are joining Frontiers in Cardiovascular Medicine and Journal of Molecular and Cellular Cardiology Plus respectively.